Sherpa Healthcare Partners
Overview
Sherpa Healthcare Partners is a healthcare-focused venture capital firm that invests in early to growth-stage companies across pharmaceuticals, biotechnologies, genetic technologies, medical technologies, and medical services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytek Biosciences | Nov 2020 | Series D | - |
| Alamar Biosciences | Feb 2024 | Series C | Co-investor |
| Genlight Neurotech | May 2026 | Series C | Co-investor |
| Insight Lifetech | Sep 2022 | Series D Extension | Lead |
| Imunopharm Technology Co., Ltd. | Jan 2019 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Raymond W. Cohen
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sherpa Healthcare Partners based?
Sherpa Healthcare Partners is headquartered in Beijing, China.
When was Sherpa Healthcare Partners founded?
Sherpa Healthcare Partners was founded in 2018.
How many portfolio companies does Sherpa Healthcare Partners have?
Sherpa Healthcare Partners has 60 portfolio companies in Caplight's dataset.
What are some companies in Sherpa Healthcare Partners's portfolio?
Portfolio companies visible on Caplight include Cytek Biosciences, Alamar Biosciences, Genlight Neurotech, Insight Lifetech, Imunopharm Technology Co., Ltd..
What was Sherpa Healthcare Partners's most recent investment shown here?
Sherpa Healthcare Partners's most recent investment in this portfolio sample was in Genlight Neurotech in 2026.
What sectors does Sherpa Healthcare Partners focus on?
Sherpa Healthcare Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Sherpa Healthcare Partners focus on?
Sherpa Healthcare Partners typically invests at the Early stage.
What is Sherpa Healthcare Partners's AUM?
Sherpa Healthcare Partners's assets under management are estimated between $250.0M and $500.0M.